Evidence map›Paper›PMID 35392379›Full record

ArticleMetabolism open2022

Lack of association between B 12 and Body Mass Index among Saudi multiple sclerosis patients.

N Alsomali, R Alsharif, B Albalawi, R Alharthi, W Junaidallah, S Alshammari, F Alhawiti, A Alenezi, R Alarieh, W Alsaeed and 1 more

Open access · goldAbstract read
In one paragraph

Article in Metabolism open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

N AlsomaliResearch Centre, Neuroscience Department, King Fahad Medical City, Riyadh, Saudi Arabia.
R AlsharifResearch Centre, Neuroscience Department, King Fahad Medical City, Riyadh, Saudi Arabia.
B AlbalawiTabuk University, Tabuk, Saudi Arabia.
R AlharthiTabuk University, Tabuk, Saudi Arabia.
W JunaidallahAlmaarefa University, Riyadh, Saudi Arabia.
S AlshammariUniversity of Hail, Hail, Saudi Arabia.
F AlhawitiTabuk University, Tabuk, Saudi Arabia.
A AleneziUniversity of Hail, Hail, Saudi Arabia.
R AlariehNational Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
W AlsaeedNational Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
G AlTowaijriNational Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
King Fahd Medical City · SAUniversity of Tabuk · SAUniversity of Ha'il · SAAlfaisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. It is an autoimmune disease of multifactorial etiology, linked to a variety of genetic and well-defined environmental factors. It typically affects more women than men and more frequently affects adults aged 20-45 years. Besides, vitamin B12 deficiency and obesity are associated with exacerbating central nervous system inflammation and a higher clinical disability. Objective: The study aims to determine the association of the vitamin B12 serum concentration with the Body Mass Index BMI, thyroid-stimulating hormone serum levels and MS clinical features in Saudi MS patients. Methods and results: This is a retrospective cohort study, and data were collected from the MS database at the King Fahad Medical City Multiple Sclerosis Clinic, from December 2015 to December 2019. Data were entered and analyzed using the Statistical Package for Social Sciences (SPSS ver. 20, Chicago, IL, USA). Cobalamin, also known as vitamin B12, has a reference concentration that ranges from 138 to 652 Pmol/L in adults. The patient's BMI was calculated by dividing the weight (in kilograms) by the square of the height (in square meters), expressed in kg/m Conclusion: These findings revealed no association between serum vitamin B12 concentration and TSH, BMI in MS clinical parameters, however, further studies are required to validate these results.

Indexed as

Body mass indexMultiple sclerosisVitamin B12

Identifiers

PMID35392379
PMCPMC8980604
OpenAlexW4221070366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.